Search results for "OUTBREAK"

showing 10 items of 812 documents

Analysis of the Possible Persistent Genotoxic Damage in Workers Linked to the Ardystil Syndrome

2016

[EN] Background: A combination of several factors including a change in the paint application system; a lack of proper hygiene; and inadequate safety measures caused a severe health impact in the workers of some textile painting factories. This outbreak, mainly characterized by respiratory disorders, caused the death of six people and it has been classified as Ardystil syndrome. Materials and Methods: Fifty-two workers involved in the outbreak and 48 healthy subjects not known to have exposed to the potentially mutagenic agents participated in the study. The program evaluated possible genotoxic damage through the sister chromatid exchange (SCE) cytogenetic biomarker assay. We determined the…

Male0301 basic medicineHealth impactPhysiologySister chromatid exchangeINGENIERIA NUCLEARToxicology03 medical and health sciencesOccupational ExposureHumansMedicineGenetics (clinical)business.industrySignificant differenceHealthy subjectsOutbreakSyndromeGeneral MedicineRespiration Disorders030104 developmental biologyTextile IndustryDistribution patternBiomarker (medicine)FemalebusinessSister Chromatid ExchangeDNA DamageGenetic Testing and Molecular Biomarkers
researchProduct

Outbreak of IMI-1 Carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean)

2018

International audience; The spread of carbapenemase-producing Enterobacteriaceae in the Southwest Indian Ocean islands is poorly known. Here we describe an outbreak of colistin-resistant Enterobacter cloacae harbouring blaIMI-1 in the French overseas department of Mayotte. Between October 2015 and January 2017, all isolates of imipenem-non-susceptible E. cloacae at Mayotte Medical Center and University Hospital of Reunion Island were screened for carbapenemase production. Positive isolates were typed by pulsed-field gel electrophoresis and whole-genome sequencing (WGS)-based multilocus sequence typing (MLST), and all β-lactamase genes were identified by PCR and sequencing. Resistance profil…

Male0301 basic medicineImipenembla(IMI-1)Carbapenem-resistant enterobacteriaceaeComorosDisease Outbreaks[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologyPharmacology (medical)Enterobacteriaceae InfectionsGeneral MedicineMiddle AgedFrench overseas islandAnti-Bacterial AgentsElectrophoresis Gel Pulsed-Field3. Good healthInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyFemalemedicine.drugAdultErtapenemMicrobiology (medical)Adolescent030106 microbiologyMayotteMicrobial Sensitivity TestsBiologybeta-LactamasesMicrobiologyCarbapenemaseYoung Adult03 medical and health sciencesBacterial Proteins[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyEnterobacter cloacaePulsed-field gel electrophoresismedicineHumansEtestColistinOutbreakOutbreakbiology.organism_classificationCephalosporinsImipenemCarbapenem-Resistant EnterobacteriaceaeCarbapenemsColistinMultilocus sequence typingEnterobacter cloacaeGenome BacterialMultilocus Sequence Typing
researchProduct

Waterborne Norovirus outbreak at a seaside resort likely originating from municipal water distribution system failure

2018

AbstractIn May 2016 a Norovirus (NoV) gastroenteritis outbreak involved a high school class visiting a seaside resort near Taormina (Mascali, Sicily). Twenty-four students and a teacher were affected and 17 of them showed symptoms on the second day of the journey, while the others got ill within the following 2 days. Symptoms included vomiting, diarrhoea and fever, and 12 students required hospitalisation. Stool samples tested positive for NoV genome by Real-Time polymerase chain reaction assay in all 25 symptomatic subjects. The GII.P2/GII.2 NoV genotype was linked to the outbreak by ORF1/ORF2 sequence analysis. The epidemiological features of the outbreak were consistent with food/waterbo…

Male0301 basic medicineSettore MED/07 - Microbiologia E Microbiologia ClinicaVeterinary medicinemedicine.medical_specialtywaterborneAdolescentEpidemiology030106 microbiologySewagemedicine.disease_causeDisease Outbreaks03 medical and health sciences0302 clinical medicineTap waterWaterborne DiseasesGenotypeEpidemiologymedicineHumans030212 general & internal medicineSicilyFecesCaliciviridae InfectionsNoroviruOriginal Paperbusiness.industryDrinking WaterNorovirusOutbreakWaterborne diseasesmedicine.diseaseGastroenteritisInfectious DiseasesGeographyNorovirusFemalegenotype GII.P2/GII.2businessgastroenteritis outbreakEpidemiology and Infection
researchProduct

Trends of influenza B during the 2010–2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisatio…

2017

Influenza A and B viruses are responsible for respiratory infections, representing globally seasonal threats to human health. The 2 viral types often co-circulate and influenza B plays an important role in the spread of infection. A 6-year retrospective surveillance study was conducted between 2010 and 2016 in 2 large administrative regions of Italy, located in the north (Liguria) and in the south (Sicily) of the country, to describe the burden and epidemiology of both B/Victoria and B/Yamagata lineages in different healthcare settings. Influenza B viruses were detected in 5 of 6 seasonal outbreaks, exceeding influenza A during the season 2012–2013. Most of influenza B infections were found…

Male0301 basic medicinevirusesInfluenza B viruDisease OutbreaksHuman health0302 clinical medicineRetrospective StudieEpidemiologyImmunology and Allergy030212 general & internal medicinehospitalChildSicilyB/Victoriaeducation.field_of_studyDisease OutbreakVaccinationvirus diseasesB/Victoria; B/Yamagata; community; hospital; Influenza type B; lineage; vaccine-mismatch; Immunology and Allergy; Immunology; Pharmacologyvaccine-mismatchInfluenza type BInfluenza A viruInfluenza A virusInfluenza VaccinesChild PreschoolcommunityCommunity settingFemaleSeasonsInfluenza VaccineHumanResearch Papermedicine.medical_specialty030106 microbiologyImmunologyPopulationEpidemic03 medical and health sciencesInfluenza HumanmedicineHumansEpidemicseducationRetrospective StudiesPharmacologyInfluenza immunisationbusiness.industryOutbreakInfluenza aVirologyInfluenza B virusVaccine mismatchSeasonbusinessB/YamagatalineageDemographyHuman Vaccines & Immunotherapeutics
researchProduct

Clinical and demographic characteristics of patients dying from COVID-19 in Italy vs China.

2020

Abstract Coronavirus disease 2019 (COVID‐19), an infectious outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2),1 has now progressed to global pandemic.2 Besides the compelling need to understand the novel biological pathways underlying the virulence and pathogenicity of SARS‐CoV‐2 in humans to enable the development of appropriate interventions and therapies,3,4 the noticeable difference in mortality rates between Asian and European populations is one of the most significant issues demanding the attention of biologists, epidemiologists and clinicians around the world. This article is protected by copyright. All rights reserved.

Male2019-20 coronavirus outbreakChinaCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia Viralcoronavirusmedicine.disease_causeepidemicsCOVID-19; comorbidity; coronavirus; epidemics; mortality; outbreakCOVID‐19VirologyMedicineHumansChinaPandemicsLetter to the EditorCoronavirusDemographyoutbreakbusiness.industrySARS-CoV-2OutbreakCOVID-19Middle Agedmedicine.diseaseVirologyComorbiditymortalitycomorbidityInfectious DiseasesItalyFemalebusinessJournal of medical virology
researchProduct

Correction to: The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome

2021

Although immune modulation is a promising therapeutic avenue in coronavirus disease 2019 (COVID-19), the most relevant targets remain to be found. COVID-19 has peculiar characteristics and outcomes, suggesting a unique immunopathogenesis.Thirty-six immunocompetent non-COVID-19 and 27 COVID-19 patients with severe pneumonia were prospectively enrolled in a single center, most requiring intensive care. Clinical and biological characteristics (including T cell phenotype and function and plasma concentrations of 30 cytokines) and outcomes were compared.At similar baseline respiratory severity, COVID-19 patients required mechanical ventilation for significantly longer than non-COVID-19 patients …

Male2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Critical CareSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralMEDLINElcsh:MedicineLymphocyte ActivationSeverity of Illness IndexGeneral Biochemistry Genetics and Molecular BiologyImmunophenotypingmedicineHumansAgedAged 80 and overInnate immune systembusiness.industrySARS-CoV-2lcsh:RCorrectionCOVID-19General MedicineMiddle Agedmedicine.diseasePrognosisRespiration ArtificialImmunity InnatePneumoniaImmunologyFemaleFrancebusinessJournal of Translational Medicine
researchProduct

Treatment of COVID-19 with MSCs: how does it work?

2021

The infusion of coronavirus disease 2019 (COVID-19) patients with mesenchymal stem cells (MSCs) potentially improves clinical symptoms, but the underlying mechanism remains unclear. We conducted a randomized, single-blind, placebo-controlled (29 patients/group) phase II clinical trial to validate previous findings and explore the potential mechanisms. Patients treated with umbilical cord-derived MSCs exhibited a shorter hospital stay (P = 0.0198) and less time required for symptoms remission (P = 0.0194) than those who received placebo. Based on chest images, both severe and critical patients treated with MSCs showed improvement by day 7 (P = 0.0099) and day 21 (P = 0.0084). MSC-treated pat…

Male2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)T-LymphocytesB-Lymphocyte SubsetsAntibodies ViralMesenchymal Stem Cell TransplantationExtracellular TrapsGeneral Biochemistry Genetics and Molecular BiologyArticleImmunomodulationMiceMedicineAnimalsHumansGeneral Environmental ScienceAgedVenous Thrombosisbusiness.industrySARS-CoV-2Mesenchymal stem cellCOVID-19Middle AgedVirologyResearch HighlightMice Inbred C57BLCytoskeletal ProteinsDisease Models AnimalMechanisms of diseaseC-Reactive ProteinWork (electrical)Leukocytes MononuclearMesenchymal stem cellsCytokinesFemaleGeneral Agricultural and Biological SciencesbusinessScience China. Life Sciences
researchProduct

Hospitalizations for Stroke in France During the COVID-19 Pandemic Before, During, and After the National Lockdown.

2021

Background and Purpose: In France, the entire population was put under a total lockdown from March 17 to May 11, 2020 during the peak of the coronavirus disease 2019 (COVID-19) pandemic. Whether the lockdown had consequences on the management of medical emergencies such as stroke and transient ischemic attack (TIA) has yet to be fully evaluated. This article describes hospitalization rates for acute stroke in 2 French regions that experienced contrasting rates of COVID-19 infection, before, during, and after the nationwide lockdown (January to June 2020). Methods: All patients admitted for acute stroke/TIA into all public and private hospitals of the 2 study regions were included. Data wer…

Male2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)EpidemiologyPandemicmedicineHumanscardiovascular diseasesStrokePandemicsAgedRetrospective StudiesAdvanced and Specialized NursingAged 80 and overEntire populationbusiness.industryIncidence (epidemiology)COVID-19Middle Agedmedicine.diseaseHospitalizationStrokeCommunicable Disease ControlFemaleNeurology (clinical)FranceCardiology and Cardiovascular MedicinebusinessDemographyStroke
researchProduct

Assessing the potential association between SARS-CoV-2 RNA load in the respiratory tract and COVID-19 mortality.

2020

Special Issue on New coronavirus (2019‐nCoV or SARS‐CoV‐2) and the outbreak of the respiratory illness (COVID‐19): Part‐XI

Male2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Respiratory System03 medical and health sciences0302 clinical medicineVirologyInternal medicineMedicineHumans030212 general & internal medicineAgedbusiness.industrySARS-CoV-2RNACOVID-19Middle AgedViral LoadVirologyInfectious Diseasesmedicine.anatomical_structureHospital admissionRNA Viral030211 gastroenterology & hepatologyFemalebusinessBiomarkersRespiratory tractJournal of medical virology
researchProduct

Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism…

2021

Male2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Unfractionated heparinLetter to the Editors-in-ChiefCohort StudiesFibrin Fibrinogen Degradation ProductsInternal medicineD-dimerHumansMedicineIn patientHeparinbusiness.industryPulmonary embolismCOVID-19HematologyHeparinmedicine.diseaseCOVID-19 Drug TreatmentPulmonary embolismRadiological weaponD-dimerbusinessCohort studymedicine.drug
researchProduct